JAIME WHITLOW: Open Payments
NPI 1184863771 · STUART, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 55 payments from 20 companies in 2025. Trend: 2023 $1,580 · 2024 $1,406 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $206 |
| PFIZER INC. | 11 | $141 |
| GENZYME CORPORATION | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Exact Sciences Corporation | 2 | $49 |
| Novo Nordisk Inc | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Amgen Inc. | 2 | $34 |
Products named: QULIPTA, NURTEC ODT, DUPIXENT, VRAYLAR, CAPLYTA, Ozempic, HETLIOZ, INGREZZA.
Industry payments across VA — which companies pay providers there.
